Lymphoma, B Cell
144 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies (NCT00051597) | Seagen Inc. | |
| A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis (NCT00210340) | International Extranodal Lymphoma Study Group (IELSG) |
Track Lymphoma, B Cell automatically
Every clearance here is in the API, with alerts when new ones post.